triazinate has been researched along with Kidney Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bukowski, RM; LoBuglio, A; McCracken, J; Pugh, R | 1 |
| Banner, RL; Benjamin, RS; Bodey, GP; Burgess, MA; Freireich, EJ; Gutterman, JU; Murphy, WK; Richman, SP; Rodriguez, V; Valdivieso, M | 1 |
2 other study(ies) available for triazinate and Kidney Neoplasms
| Article | Year |
|---|---|
Phase II trial of Baker's antifol in metastatic renal cell carcinoma: a Southwest Oncology Group Study.
Topics: Adenocarcinoma; Adult; Aged; Diarrhea; Drug Evaluation; Female; Granulocytes; Humans; Kidney Neoplasms; Leukocyte Count; Male; Middle Aged; Nausea; Platelet Count; Triazines; Vomiting | 1980 |
Phase 2 study with Baker's Antifol in solid tumors.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Carcinoma, Squamous Cell; Colonic Neoplasms; Drug Eruptions; Female; Folic Acid Antagonists; Head and Neck Neoplasms; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Melanoma; Middle Aged; Neoplasms; Rectal Neoplasms; Remission, Spontaneous; Sarcoma; Stomatitis; Triazines | 1977 |